Publishing research using ab38618? Please let us know so that we can cite the reference in this datasheet.

ab38618 has been referenced in 20 publications.

  • Li J  et al. miR-186 reverses cisplatin resistance and inhibits the formation of the glioblastoma-initiating cell phenotype by degrading Yin Yang 1 in glioblastoma. Int J Mol Med 43:517-524 (2019). PubMed: 30365062
  • Liu L  et al. CP-31398 attenuates endometrial cancer cell invasion, metastasis and resistance to apoptosis by downregulating MDM2 expression. Int J Oncol 54:942-954 (2019). PubMed: 30628640
  • Liang Z  et al. Tip60-siRNA regulates ABCE1 acetylation to suppress lung cancer growth via activation of the apoptotic signaling pathway. Exp Ther Med 17:3195-3202 (2019). PubMed: 30936993
  • Wei Y  et al. Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16. Life Sci 225:55-63 (2019). PubMed: 30946839
  • Bai Y  et al. Golgi integral membrane protein 4 manipulates cellular proliferation, apoptosis, and cell cycle in human head and neck cancer. Biosci Rep 38:N/A (2018). PubMed: 30068697
  • Tian M  et al. Icariin reduces human colon carcinoma cell growth and metastasis by enhancing p53 activities. Braz J Med Biol Res 51:e7151 (2018). PubMed: 30088538
  • Yang YN  et al. miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP-a in glioblastoma. Oncol Lett 15:7563-7570 (2018). PubMed: 29725461
  • Jin LZ  et al. Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. Biosci Rep 38:N/A (2018). PubMed: 29700214
  • Guo J  et al. Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2. Cancer Cell Int 18:98 (2018). PubMed: 30008615
  • Xing Y  et al. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway. Cell Commun Signal 16:43 (2018). PubMed: 30064446
  • Chen M  et al. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer. Biochem Biophys Res Commun 507:74-82 (2018). PubMed: 30454896
  • Vecino R  et al. The MDM2-p53 pathway is involved in preconditioning-induced neuronal tolerance to ischemia. Sci Rep 8:1610 (2018). PubMed: 29371613
  • Wang MS  et al. Iron oxide magnetic nanoparticles combined with actein suppress non-small-cell lung cancer growth in a p53-dependent manner. Int J Nanomedicine 12:7627-7651 (2017). WB ; Human . PubMed: 29089760
  • Cui X  et al. Stromal interaction molecule 1 regulates growth, cell cycle, and apoptosis of human tongue squamous carcinoma cells. Biosci Rep 37:N/A (2017). WB ; Human . PubMed: 28108672
  • Liu WB  et al. Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance. Oncotarget 8:93984-93997 (2017). WB . PubMed: 29212203
  • Zhang Y  et al. AGO2 involves the malignant phenotypes and FAK/PI3K/AKT signaling pathway in hypopharyngeal-derived FaDu cells. Oncotarget 8:54735-54746 (2017). PubMed: 28903378
  • Rivera-Calderón LG  et al. Alterations in PTEN, MDM2, TP53 and AR protein and gene expression are associated with canine prostate carcinogenesis. Res Vet Sci 106:56-61 (2016). PubMed: 27234536
  • Saito R  et al. Systems biology analysis reveals role of MDM2 in diabetic nephropathy. JCI Insight 1:e87877 (2016). PubMed: 27777973
  • Wang J  et al. Mechanism of QSYQ on anti-apoptosis mediated by different subtypes of cyclooxygenase in AMI induced heart failure rats. BMC Complement Altern Med 15:352 (2015). WB ; Rat . PubMed: 26445960
  • Geatrell JC  et al. Apoptosis gene profiling reveals spatio-temporal regulated expression of the p53/Mdm2 pathway during lens development. Exp Eye Res 88:1137-51 (2009). WB ; Mouse, Chicken . PubMed: 19450442

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up